| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 05/02/2007 | CN1955178A New benzimidazole derivative |
| 05/01/2007 | US7211668 PNA monomer and precursor |
| 05/01/2007 | US7211667 Trans,trans-1,3-butadiene-1,4-di-n-butyl-1-carboxyl-4-carboxamide; treating hypertension, associated with the decreased binding of magnesium to the plasma membranes of cells |
| 05/01/2007 | CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents |
| 05/01/2007 | CA2162630C Sulfonamides |
| 05/01/2007 | CA2132131C 3-arylbenzofuranones as stabilisers |
| 04/26/2007 | WO2007047401A2 A1 adenosine receptor agonists |
| 04/26/2007 | US20070093659 Methyl-2-[4-methyl-2-(1-methyl-piperidin-4-ylamino)-benzoimidazol-1-ylmethyl]-pyridin-3-ol; antiviral activity |
| 04/26/2007 | US20070093511 Anhydrous Crystal Form of Valaciclovir Hydrochloride |
| 04/26/2007 | US20070093510 Phosphodiesterase 4 inhibitors |
| 04/26/2007 | US20070093446 Orally bioavailable compounds and methods for inhibiting platelet aggregation |
| 04/26/2007 | CA2625783A1 A1 adenosine receptor agonists |
| 04/25/2007 | CN1312152C New purine derivatives |
| 04/24/2007 | US7208598 Trans-N2-(4-aminocyclohexyl)-N6-[2-[[[4-choro-3-trifluoromethyl)-phenyl]-methyl]-amino]-ethyl]-9-cyclopentyl-9H-purin-2,6-diamine trihydrochloride; cycline-dependent kinase proteins (cdk) inhibitor; animitotic, antitumor agents |
| 04/24/2007 | US7208557 Functional monomers for molecular recognition and catalysis |
| 04/19/2007 | WO2006128693A3 2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system |
| 04/19/2007 | WO2006083553A3 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase |
| 04/19/2007 | WO2005077950A3 Medicaments with hm74a receptor activity |
| 04/19/2007 | US20070088062 N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; keratinization disorder such as rosacea, acne, and psoriasis; potent inhibitors of the retinoic acid-metabolism; show little or no endocrinological side-effects; |
| 04/19/2007 | US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi |
| 04/18/2007 | EP1775297A2 Adenosine receptor antagonists and methods of making and using the same |
| 04/18/2007 | EP1773826A2 C-met modulators and method of use |
| 04/18/2007 | EP1265890B1 Stereoselective synthesis of nucleoside analogues |
| 04/18/2007 | EP1019403B1 Process for preparing purine derivatives |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |
| 04/17/2007 | CA2277151C Synthesis of acyclic nucleoside derivatives |
| 04/17/2007 | CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof |
| 04/17/2007 | CA2188181C Preparation of purines |
| 04/17/2007 | CA2141589C Antiretroviral enantiomeric nucleotide analogs |
| 04/12/2007 | WO2007039059A1 Novel carboxylic acid derivatives |
| 04/12/2007 | US20070083048 Nonsolvate-form crystal of polymethine compound and process for producing the same |
| 04/12/2007 | US20070082874 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/11/2007 | EP1771177A2 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 04/11/2007 | EP1519938B1 Synthesis of purine derivatives |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | CN1946405A Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives |
| 04/10/2007 | US7202252 Xanthines 3-substituted with an arylalkylene or N-heteroarylalkylene group and 8-substituted with a heteroarylalkylene group, e.g. 3-[2-(4-Aminophenyl)ethyl]-1-propyl-8-[(3-pyridyl)methyl]xanthine and 3-[2-(4-Aminophenyl)ethyl]-1-propyl-8-[(4-thiazolyl)methyl]xanthine |
| 04/10/2007 | US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/05/2007 | WO2007037518A1 Mutilin derivative and pharmaceutical composition containing the same |
| 04/05/2007 | WO2006084030B1 Small-molecule hsp90 inhibitors |
| 04/05/2007 | WO2006058338A3 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor |
| 04/05/2007 | US20070078148 Agents for preventing and/or treating higher brain dysfunctions |
| 04/04/2007 | EP1768983A2 Fused heterocyclic kinase inhibitors |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/03/2007 | US7199127 (2-chloropurin-9-yl)-tetrahydrothiophene-3,4-diols; anticarcinogenic agents selective to A3 adenosine receptors; breast cancer |
| 04/03/2007 | CA2309350C Purine derivatives and medicaments comprising the same as active ingredient |
| 04/03/2007 | CA2201096C Solid dispersion and solid dispersion dosage form of xanthine derivative |
| 03/29/2007 | WO2007035873A1 Purinone derivatives for treating neurodegenerative diseases |
| 03/29/2007 | WO2007034917A1 Novel adenine compound |
| 03/29/2007 | WO2007034916A1 Novel adenine compound |
| 03/29/2007 | WO2007034882A1 Novel adenine compound |
| 03/29/2007 | WO2007034881A1 Novel adenine compound |
| 03/29/2007 | WO2007034817A1 Novel adenine compound |
| 03/29/2007 | WO2007034185A1 Purine compounds as hsp90 protein inhibitors for the treatment of cancer |
| 03/29/2007 | WO2007034173A1 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 03/29/2007 | US20070072866 that inhibit the metabolic activity of the enzyme glycogen synthase kinase 3 beta (GSK-3 beta), which is believed to cause the neurodegeneration that results in diseases of the central nervous system; enzyme inhibitors |
| 03/29/2007 | US20070072844 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/29/2007 | US20070072843 Pyridyl substituted xanthines |
| 03/28/2007 | CN1938307A 9-substituted 8-oxoadenine compound |
| 03/28/2007 | CN1307177C Synthesis and purification of valacyclovir |
| 03/28/2007 | CN1307176C Novel alkoxypyridine-derivatives |
| 03/27/2007 | US7196103 Indole derivatives as factor Xa inhibitors |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196093 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant |
| 03/27/2007 | CA2208018C Sulfonamides |
| 03/22/2007 | WO2007031726A1 Purine derivatives having immuno-modulating properties |
| 03/22/2007 | US20070066631 A2B adenosine receptor antagonists; asthma, improving insulin sensitivity |
| 03/22/2007 | US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | US20070066560 Partial and full agonists of A1 adenosine receptors |
| 03/22/2007 | US20070065360 Nonpolar thymidine analogs |
| 03/21/2007 | EP1697394B1 Comt inhibitors |
| 03/21/2007 | CN1931859A New fused imidazole derivative |
| 03/20/2007 | US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects |
| 03/20/2007 | US7192952 2,6-Dioxo-1,2,3,6-tetrahydropurine derivatives; dipeptidyl peptidase IV inhibitors for diabetes and obesity |
| 03/15/2007 | WO2007030657A1 CRYSTALLINE FORMS OF [1S-(1α, 3α, 4β)]-2- AMINO-1,9-DIHYDRO-9-[4-HYDROXY-3-(HYDROXYMETHYL)-2- METHYLENECYCLOPENTYL]-6H-PURIN-6-ONE |
| 03/15/2007 | WO2006128692A3 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 03/15/2007 | US20070060599 Crystalline forms of [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
| 03/15/2007 | US20070060598 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 03/15/2007 | US20070060503 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/14/2007 | EP1761540A1 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 03/14/2007 | EP1761535A1 Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 03/14/2007 | EP1761534A2 New analogs of nitrobenzylthioinosine |
| 03/14/2007 | EP1761268A2 Pyrrolotriazine kinase inhibitors |
| 03/13/2007 | US7189849 Synthesis of acyclic nucleoside derivatives |
| 03/13/2007 | US7189730 A2A adenosine receptor antagonists |
| 03/13/2007 | US7189716 anticarcinogenic agents |
| 03/13/2007 | CA2387533C Purine derivatives |
| 03/13/2007 | CA2351049C Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers |
| 03/07/2007 | EP1758905A1 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a ddp-iv inhibitor |
| 03/07/2007 | EP1758596A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 03/07/2007 | CN1303078C Process for preparing effective constituent in tea |
| 03/06/2007 | US7186714 administering drugs such as 3-[2-(Cyclopentylamino)-4-pyrimidinyl]-2-(4-fluorophenyl)imidazo[1,2-a]pyridin-8-amine, for therapy of viral diseases caused by DNA viruses |
| 03/01/2007 | WO2007025090A2 Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase |
| 03/01/2007 | WO2007024707A2 Tlr agonists |
| 03/01/2007 | WO2006085219A3 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 03/01/2007 | WO2006014325A3 C-met modulators and method of use |
| 03/01/2007 | US20070049591 Inhibitors of MAPK/Erk Kinase |